ÂÜÀòÂÒÂ×

Jessy Presumey is a seasoned researcher with extensive experience in immunology and molecular medicine. Currently serving as Head of Research at CYTEA|BIO since November 2022, Jessy previously held roles such as Head of Science and Chief Operating Officer at MedXCell NKar, and Project Manager R&D. A former Postdoctoral Researcher at Boston Children's Hospital, Jessy developed innovative mouse models utilizing CRISPR/Cas9 technology and explored the implications of Complement C4 in neural development and lupus. Jessy earned a PhD in Immunology from the University of Montpellier and has additional degrees in Immunology and Biology from Aix-Marseille University, Université de Bourgogne, and University of Montpellier.